Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.12
-0.4000-1.40%
Post-market: 28.12-0.00050.00%19:59 EDT
Volume:30.49M
Turnover:861.16M
Market Cap:159.88B
PE:37.01
High:28.59
Open:28.45
Low:28.08
Close:28.52
52wk High:29.21
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.99
T/O Rate:0.54%
Dividend:1.72
Dividend Rate:6.12%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.88
PE(LYR):20.61

Loading ...

Pfizer Canada: Vaccine Will be Available Through Various Distribution Channels in Coming Days and Weeks

THOMSON REUTERS
·
Sep 18

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

Lilly: Foundayo Has Captured Over 30% Of New Patient Share In The U.S. Oral Weight-Loss Drug Market

Bellwether Stocks Movement
·
Sep 15

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

AstraZeneca's Breast Cancer Drug Etcamah Hits A Phase 3 Setback, Clouding Billions In Potential Sales

Options & Short Sell
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Dow Jones Top Company Headlines at 1 am ET: Biggest AI Rivals Agree They Need to Slow it Down | Amazon ...

Dow Jones
·
Sep 14

GE HealthCare Plans $1 Billion Sofie Deal To Tap Fast-Growing Radiopharmaceuticals Market

Options & Short Sell
·
Sep 14

Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations with 21 Air After Miami Crash | Pfizer ...

Dow Jones
·
Sep 14

Pfizer Makes an Unusual Enemy in $2 Billion Fight over Unwanted Covid-19 Vaccines

Dow Jones
·
Sep 13

Pfizer Stock Eyes New Boom With Obesity And Alopecia Bets

TIPRANKS
·
Sep 12

AstraZeneca's Breast Cancer Pill Fails in Late-Stage Trial

Reuters
·
Sep 12

For Novartis, M&A is Both a Disease and Cure

Reuters
·
Sep 11

Pfizer Advances Alopecia Areata Drug Ritlecitinib in Key Phase 3 Trial

TIPRANKS
·
Sep 11

Novartis India Hits Record High After Recent Acquisition, Distribution Deal

Reuters
·
Sep 10

TwoStep Therapeutics Raises $62.5 Million in Series a Led by Insight Partners, Medical Excellence Capital

Reuters
·
Sep 10

BMO Capital Adjusts Price Target on Pfizer to $35 From $30, Keeps Outperform Rating

MT Newswires Live
·
Sep 09

NYSE Most Active Issues

Dow Jones
·
Sep 09

Pfizer Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Pfizer CEO Bourla to Speak at Morgan Stanley Global Healthcare Conference Webcast

Reuters
·
Sep 08